• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对源自LNCaP细胞、前列腺癌肿瘤及前列腺癌患者血清的前列腺特异性膜抗原的糖基化分析。

Analysis of glycosylation of prostate-specific membrane antigen derived from LNCaP cells, prostatic carcinoma tumors, and serum from prostate cancer patients.

作者信息

Holmes E H, Greene T G, Tino W T, Boynton A L, Aldape H C, Misrock S L, Murphy G P

机构信息

Pacific Northwest Cancer Foundation, Department of Cell Surface Biochemistry, Seattle, Washington, USA.

出版信息

Prostate Suppl. 1996;7:25-9.

PMID:8950359
Abstract

BACKGROUND

Prostate-specific membrane antigen (PSMA) has been detected in human prostatic cancer tissues, serum, and seminal fluid based on Western blot data with the monoclonal antibody 7E11.C5. The reactive protein is very similar in size to that from human prostatic carcinoma LNCaP cells and corresponds to a protein with a molecular size of about 110,000 daltons. Given that PSMA is known to be a 750 amino acid protein of about 84,000 daltons, a substantial portion, perhaps 20-25% of the native molecular weight, is composed of carbohydrates.

METHODS

In this study, we have begun initial analyses of the glycosylation of the PSMA protein from multiple sources using a variety of exo- and endoglycosidase treatments.

RESULTS

The results indicate that the carbohydrate is primarily N-linked and in each case the deglycosylated protein has an apparent molecular weight of about 86,000 daltons. The glycan present on in vivo-derived PSMA from tumor tissue or serum was found to be primarily N-linked complex type. A small amount of O-linked glycan also appears to be present. In contrast, only high mannose-type N-linked glycans are present on the PSMA from LNCaP cells.

CONCLUSIONS

Oligosaccharides present on PSMA derived from both tissue culture LNCaP cells and in vivo specimens are primarily N-linked and comprise about 20-25% of the native molecular weight. N-linked glycans of PSMA derived from in vivo sources were found to be complex type, lacking polylactosamine structures. In contrast, LNCaP cells express only high mannose-type structures. These results will be useful in our ongoing efforts to develop monoclonal antibodies which are specific for protein epitopes present in the extracellular domain of the protein.

摘要

背景

基于使用单克隆抗体7E11.C5的蛋白质印迹数据,在人前列腺癌组织、血清和精液中检测到前列腺特异性膜抗原(PSMA)。反应性蛋白的大小与人前列腺癌LNCaP细胞中的蛋白非常相似,对应于一种分子量约为110,000道尔顿的蛋白质。鉴于已知PSMA是一种约84,000道尔顿的750个氨基酸的蛋白质,相当一部分,可能占天然分子量的20 - 25%,由碳水化合物组成。

方法

在本研究中,我们开始使用多种外切糖苷酶和内切糖苷酶处理对来自多个来源的PSMA蛋白的糖基化进行初步分析。

结果

结果表明,碳水化合物主要是N - 连接的,并且在每种情况下,去糖基化蛋白的表观分子量约为86,000道尔顿。在肿瘤组织或血清中体内来源的PSMA上存在的聚糖主要是N - 连接的复合型。也似乎存在少量O - 连接的聚糖。相比之下,LNCaP细胞的PSMA上仅存在高甘露糖型N - 连接聚糖。

结论

来自组织培养LNCaP细胞和体内标本的PSMA上存在的寡糖主要是N - 连接的,约占天然分子量的20 - 25%。发现来自体内来源的PSMA的N - 连接聚糖是复合型的,缺乏多乳糖胺结构。相比之下,LNCaP细胞仅表达高甘露糖型结构。这些结果将有助于我们正在进行的开发针对该蛋白细胞外结构域中存在的蛋白质表位的单克隆抗体的工作。

相似文献

1
Analysis of glycosylation of prostate-specific membrane antigen derived from LNCaP cells, prostatic carcinoma tumors, and serum from prostate cancer patients.对源自LNCaP细胞、前列腺癌肿瘤及前列腺癌患者血清的前列腺特异性膜抗原的糖基化分析。
Prostate Suppl. 1996;7:25-9.
2
Measurement of prostate-specific membrane antigen in the serum with a new antibody.使用一种新型抗体检测血清中的前列腺特异性膜抗原。
Prostate. 1996 Apr;28(4):266-71. doi: 10.1002/(SICI)1097-0045(199604)28:4<266::AID-PROS7>3.0.CO;2-B.
3
Prostate-specific membrane antigen and its truncated form PSM'.前列腺特异性膜抗原及其截短形式PSM'。
Prostate. 2009 Apr 1;69(5):471-9. doi: 10.1002/pros.20894.
4
Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins.糖基化模式的改变有助于区分正常来源和肿瘤来源的前列腺特异性抗原(PSA)。
Glycobiology. 2003 Jun;13(6):457-70. doi: 10.1093/glycob/cwg041. Epub 2003 Jan 3.
5
Constitutive and antibody-induced internalization of prostate-specific membrane antigen.前列腺特异性膜抗原的组成型及抗体诱导的内化作用
Cancer Res. 1998 Sep 15;58(18):4055-60.
6
Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA.前列腺癌血清中前列腺特异性抗原的不同聚糖结构与精浆前列腺特异性抗原的关系
Glycobiology. 2006 Feb;16(2):132-45. doi: 10.1093/glycob/cwj042. Epub 2005 Sep 21.
7
A novel human prostate-specific gene-1 (HPG-1): molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis.一种新型人类前列腺特异性基因-1(HPG-1):分子克隆、测序及其在前列腺癌发生中的潜在作用。
Cancer Res. 2003 Jan 15;63(2):329-36.
8
Purification of prostate-specific membrane antigen using conformational epitope-specific antibody-affinity chromatography.使用构象表位特异性抗体亲和色谱法纯化前列腺特异性膜抗原
Protein Expr Purif. 2006 Oct;49(2):251-5. doi: 10.1016/j.pep.2006.05.008. Epub 2006 May 22.
9
Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach.前列腺癌患者血清及精浆中游离和复合形式前列腺特异性抗原的寡糖谱:一种糖肽分析方法
Glycobiology. 2008 Jan;18(1):2-8. doi: 10.1093/glycob/cwm117. Epub 2007 Oct 23.
10
Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.一种前列腺特异性蛋白酪氨酸磷酸酶——前列腺酸性磷酸酶对LNCaP前列腺癌异种移植瘤的抑制作用
Prostate. 2003 Jun 1;55(4):247-58. doi: 10.1002/pros.10240.

引用本文的文献

1
Site-Specific Intact N-Linked Glycopeptide Characterization of Prostate-Specific Membrane Antigen from Metastatic Prostate Cancer Cells.转移性前列腺癌细胞中前列腺特异性膜抗原的位点特异性完整N-连接糖肽表征
ACS Omega. 2022 Aug 18;7(34):29714-29727. doi: 10.1021/acsomega.2c02265. eCollection 2022 Aug 30.
2
Glycosylation Changes in Prostate Cancer Progression.前列腺癌进展过程中的糖基化变化
Front Oncol. 2021 Dec 24;11:809170. doi: 10.3389/fonc.2021.809170. eCollection 2021.
3
Glycoforms of human prostate-specific membrane antigen (PSMA) in human cells and prostate tissue.
人前列腺特异性膜抗原(PSMA)在人细胞和前列腺组织中的糖型。
Prostate. 2022 Jan;82(1):132-144. doi: 10.1002/pros.24254. Epub 2021 Oct 18.
4
Novel Non-Congeneric Derivatives of the Choline Kinase Alpha Inhibitor ICL-CCIC-0019.胆碱激酶α抑制剂ICL-CCIC-0019的新型非同类衍生物
Pharmaceutics. 2021 Jul 14;13(7):1078. doi: 10.3390/pharmaceutics13071078.
5
A Glu-urea-Lys Ligand-conjugated Lipid Nanoparticle/siRNA System Inhibits Androgen Receptor Expression In Vivo.一种谷氨酸-尿素-赖氨酸配体共轭脂质纳米颗粒/小干扰RNA系统在体内抑制雄激素受体表达。
Mol Ther Nucleic Acids. 2016;5(8):e348. doi: 10.1038/mtna.2016.43.
6
Can glycoprofiling be helpful in detecting prostate cancer?糖蛋白分析对前列腺癌的检测有帮助吗?
Chem Zvesti. 2015 Jan;69(1):90-111. doi: 10.1515/chempap-2015-0052. Epub 2014 Nov 28.
7
A Novel Prostate-Specific Membrane-Antigen (PSMA) Targeted Micelle-Encapsulating Wogonin Inhibits Prostate Cancer Cell Proliferation via Inducing Intrinsic Apoptotic Pathway.一种新型的靶向前列腺特异性膜抗原(PSMA)的包裹汉黄芩素的胶束通过诱导内源性凋亡途径抑制前列腺癌细胞增殖。
Int J Mol Sci. 2016 May 17;17(5):676. doi: 10.3390/ijms17050676.
8
The dog prostate cancer (DPC-1) model: a reliable tool for molecular imaging of prostate tumors and metastases.犬前列腺癌(DPC-1)模型:用于前列腺肿瘤和转移灶分子成像的可靠工具。
EJNMMI Res. 2015 Dec;5(1):77. doi: 10.1186/s13550-015-0155-6. Epub 2015 Dec 30.
9
Chemically synthesized molecules with the targeting and effector functions of antibodies.具有抗体靶向和效应功能的化学合成分子。
J Am Chem Soc. 2014 Dec 31;136(52):18034-43. doi: 10.1021/ja509513c. Epub 2014 Dec 16.
10
Integration of the transcriptome and glycome for identification of glycan cell signatures.整合转录组和聚糖组以鉴定聚糖细胞特征。
PLoS Comput Biol. 2013;9(1):e1002813. doi: 10.1371/journal.pcbi.1002813. Epub 2013 Jan 10.